Cumberland Pharmaceuticals, Inc. (CPIX)
6.62
-0.17
(-2.50%)
USD |
NASDAQ |
Sep 08, 16:00
6.80
+0.18
(+2.72%)
Pre-Market: 08:08
Cumberland Pharmaceuticals Market Cap : 99.19M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 99.19M |
| September 04, 2026 | 101.74M |
| September 03, 2026 | 101.14M |
| September 02, 2026 | 97.69M |
| September 01, 2026 | 98.29M |
| August 31, 2026 | 100.24M |
| August 28, 2026 | 126.76M |
| August 27, 2026 | 129.60M |
| August 26, 2026 | 134.40M |
| August 25, 2026 | 130.35M |
| August 24, 2026 | 117.47M |
| August 21, 2026 | 114.62M |
| August 20, 2026 | 112.37M |
| August 19, 2026 | 114.62M |
| August 18, 2026 | 114.32M |
| August 17, 2026 | 115.07M |
| August 14, 2026 | 116.72M |
| August 13, 2026 | 118.37M |
| August 12, 2026 | 118.52M |
| August 11, 2026 | 119.27M |
| August 10, 2026 | 116.72M |
| August 07, 2026 | 116.87M |
| August 06, 2026 | 115.07M |
| August 05, 2026 | 113.12M |
| August 04, 2026 | 116.42M |
| Date | Value |
|---|---|
| August 03, 2026 | 107.58M |
| July 31, 2026 | 100.09M |
| July 30, 2026 | 100.84M |
| July 29, 2026 | 99.79M |
| July 28, 2026 | 102.03M |
| July 27, 2026 | 105.33M |
| July 24, 2026 | 99.04M |
| July 23, 2026 | 104.66M |
| July 22, 2026 | 106.60M |
| July 21, 2026 | 117.62M |
| July 20, 2026 | 109.38M |
| July 17, 2026 | 102.48M |
| July 16, 2026 | 114.77M |
| July 15, 2026 | 116.87M |
| July 14, 2026 | 104.66M |
| July 13, 2026 | 97.99M |
| July 10, 2026 | 88.85M |
| July 09, 2026 | 90.50M |
| July 08, 2026 | 93.64M |
| July 07, 2026 | 94.24M |
| July 06, 2026 | 92.30M |
| July 02, 2026 | 95.44M |
| July 01, 2026 | 106.83M |
| June 30, 2026 | 97.09M |
| June 29, 2026 | 102.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 648.10B |
| Eli Lilly & Co. | 1.058T |
| ANI Pharmaceuticals, Inc. | 1.613B |
| Corcept Therapeutics, Inc. | 12.30B |
| Veru, Inc. | 43.99M |
Market Cap Related Metrics
| PS Ratio | 3.168 |
| PEG Ratio | -0.0375 |
| Price to Book Value | 5.688 |
| Price to Free Cash Flow | 158.76 |
| Price | 6.62 |
| Earnings Yield | -11.02% |
| PEGY Ratio | -0.0375 |